Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,767,364,935
-
Total 13F shares
-
1,064,303,780
-
Share change
-
-2,460,163
-
Total reported value
-
$100,606,565,412
-
Put/Call ratio
-
137%
-
Price per share
-
$94.58
-
Number of holders
-
1,952
-
Value change
-
-$228,478,920
-
Number of buys
-
788
-
Number of sells
-
970
Institutional Holders of AbbVie Inc. - Common Stock (ABBV) as of Q3 2018
As of 30 Sep 2018,
AbbVie Inc. - Common Stock (ABBV) was held by
1,952 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,064,303,780 shares.
The largest 10 holders included
Capital Research Global Investors, Vanguard Group Inc, BlackRock Inc., STATE STREET CORP, Capital International Investors, Capital World Investors, NORTHERN TRUST CORP, BANK OF AMERICA CORP /DE/, GEODE CAPITAL MANAGEMENT, LLC, and Bank of New York Mellon Corp.
This page lists
1,953
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.